Bench Mark Infotech Services IPO Day 2: GMP ₹12

Welcome back, investors! We’re halfway through the subscription period for Bench Mark Infotech Services’ SME IPO on NSE, and it’s Day 2. As of today, the IPO remains open for applications, and we’re here to break down the latest subscription figures and Grey Market Premium (GMP) movements. Let’s dive into what’s happening with this offering.

Subscription Status

Looking at the subscription numbers for Bench Mark Infotech Services on Day 2, it’s an interesting picture. Currently, the subscription figures across all categories – Retail, NII (High Net-worth Individuals), and QIB (Qualified Institutional Buyers) – stand at 0x. This means that as of the end of Day 2, no applications have been formally recorded in the system for any investor category. While this might seem concerning at first glance, it’s not entirely uncommon for SME IPOs, especially in the initial days. Often, a significant portion of applications, particularly from retail investors, tend to come in towards the closing days of the IPO. The absence of QIB and NII subscriptions at this stage could indicate that these larger investors are still evaluating the opportunity or are waiting for more data to emerge.

The lot size for this IPO is 1200 shares, and the issue price is set at ₹110 per share. The IPO period runs from September 25, 2026, to September 29, 2026. The fact that we’re seeing zero subscriptions across the board on Day 2, particularly before the final push, is something to watch closely. We’ll need to see a substantial surge in interest over the next three days to ensure a successful subscription. This is the crucial period where investor sentiment truly crystallizes.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Bench Mark Infotech Services IPO is ₹12. This figure has remained unchanged from yesterday’s reported GMP. The previous GMP was also ₹12. A steady GMP, even if it’s not showing aggressive growth, can be seen as a sign of stable demand or at least a lack of negative sentiment in the unofficial market. At an issue price of ₹110 and a GMP of ₹12, the expected listing price is around ₹122 per share. This represents a potential gain of approximately 10.9% on listing day. While a ₹12 GMP isn’t a massive premium, it’s positive that it hasn’t declined. It suggests that market participants are still anticipating a modest listing gain.

The fact that the GMP has stayed put indicates a consistent, albeit not overpowering, interest. It’s not a dramatic surge, but it’s also not a dip, which is encouraging. For investors looking at the GMP, this ₹12 premium provides a baseline expectation for listing performance. However, remember that GMP is an unofficial indicator and can fluctuate.

Should You Apply?

Deciding whether to invest in Bench Mark Infotech Services IPO requires a balanced view. On one hand, the subscription figures are currently at zero, which is a point of caution. This indicates that the IPO hasn’t yet captured widespread investor attention, and a significant rush is needed in the remaining days. The lack of early traction from NIIs and QIBs might also be a factor for some to consider. However, the GMP is holding steady at ₹12, suggesting a mild positive sentiment and an expectation of a listing gain. The issue price of ₹110 with an expected listing of ₹122 offers a decent, albeit not spectacular, potential return.

As always, it’s crucial to conduct your own due diligence. Consider the company’s fundamentals, its business model, and its future prospects. The SEBI advisor’s guidelines emphasize informed decision-making. If you’re a risk-averse investor, the current subscription status might warrant a wait-and-watch approach. If you’re comfortable with the risk profile and believe in the company’s long-term potential, the current GMP could represent an attractive entry point, especially if subscriptions pick up in the final days. The bottom line is that the next few days are critical for this IPO.

View Full Bench Mark Infotech Services IPO Details